glioblastoma

Showing NaN - NaN of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma, Venous Thromboembolism, Seizures Trial in Cleveland (Apple Watch)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • Apple Watch
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Nov 13, 2023

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023

Glioblastoma Trial in Cleveland (NICO Myriad and Tissue Preservation System (TPS))

Active, not recruiting
  • Glioblastoma
  • NICO Myriad and Tissue Preservation System (TPS)
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jan 13, 2023

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Glioblastoma Trial in Worldwide (LY2157299 monohydrate, Lomustine, Placebo)

Active, not recruiting
  • Glioblastoma
  • LY2157299 monohydrate
  • +2 more
  • Birmingham, Alabama
  • +26 more
Oct 18, 2022

High Grade Glioma, Glioblastoma Trial in Cleveland (Standard Surgical Treatment, Intraoperative Electrocorticography)

Not yet recruiting
  • High Grade Glioma
  • Glioblastoma
  • Standard Surgical Treatment
  • Intraoperative Electrocorticography
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Sep 30, 2022

Glioblastoma Trial in United States (Temozolomide, Neratinib, QBS10072S)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +11 more
Aug 15, 2022

Glioblastoma, Gliosarcoma Trial in United States (drug, radiation, other)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Little Rock, Arkansas
  • +119 more
Aug 11, 2022

Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)

Recruiting
  • Glioblastoma
  • Adult-type Diffuse Gliomas
  • Beverly Hills, California
  • +83 more
Jul 25, 2022

Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)

Not yet recruiting
  • Glioblastoma Multiforme
  • Glioblastoma
  • IGV-001 Cell Immunotherapy
  • +3 more
  • Newark, Delaware
  • +22 more
Jun 24, 2022

Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

Active, not recruiting
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
May 12, 2022

Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +60 more
Apr 4, 2022

Glioblastoma Trial in Cleveland (Capecitabine, Bevacizumab)

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 22, 2022

Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma Trial in United States (lerapolturev, pembrolizumab)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • lerapolturev
  • pembrolizumab
  • San Francisco, California
  • +9 more
Nov 30, 2021

Glioblastoma Trial in United States (NeuroBlate System, Radiation therapy and temozolomide)

Terminated
  • Glioblastoma
  • NeuroBlate System
  • Radiation therapy and temozolomide
  • Saint Louis, Missouri
  • +3 more
Aug 23, 2021

Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)

Completed
  • Brain Cancer
  • +10 more
  • DNX-2401
  • pembrolizumab
  • Little Rock, Arkansas
  • +14 more
Jul 13, 2021

Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)

Terminated
  • Glioblastoma
  • +2 more
  • La Jolla, California
  • +10 more
May 12, 2021

Glioblastoma Trial in Boston, Cleveland (Nivolumab, Standard Dose Bevacizumab, Low Dose Bevacizumab)

Active, not recruiting
  • Glioblastoma
  • Boston, Massachusetts
  • +1 more
May 21, 2021

Solid Tumors, Glioblastoma Trial in Buffalo, Cleveland, San Antonio (CBL0137)

Completed
  • Solid Tumors
  • Glioblastoma
  • Buffalo, New York
  • +3 more
Dec 8, 2020

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Glioblastoma Trial in Worldwide (Depatuxizumab mafodotin, Temozolomide, Lomustine)

Completed
  • Glioblastoma
  • Depatuxizumab mafodotin
  • +2 more
  • Palo Alto, California
  • +101 more
May 8, 2020

Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,

Completed
  • Glioblastoma
  • +2 more
  • 3-Dimensional Conformal Radiation Therapy
  • +6 more
  • Mobile, Alabama
  • +329 more
Jul 22, 2019